Yasuo Kubota1, Kumiko Uryu1, Tatsuya Ito2, Tomoko Kawai3, Masafumi Seki1, Tomoya Isobe1, Tsutomu Toki2, Kenichi Yoshida4, Keisuke Kataoka4, Yuichi Shiraishi5, Kenichi Chiba5, Hiroko Tanaka5, Kentaro Ohki6, Nobutaka Kiyokawa6, Satoru Miyano4, Akira Oka1, Yasuhide Hayashi7, Seishi Ogawa4, Kiminori Terui2, Atsushi Sato8, Kenichiro Hata3, Etsuro Ito2, Junko Takita1 (1.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 2.Department of Pediatrics, Hirosaki University, Hirosaki, Japan, 3.Maternal-Fetal Biology, National Research Institute for Child Health and Development, 4.Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, 5.Human Genome Center, Institute of Medical Science, Univ Tokyo, 6.Pediatric Hematology, National Research Institute for Child Health and Development, 7.Department of Hematology and Oncology, Gunma Children's Medical Center, 8.Department of Hematology and Oncology, Miyagi Children's Hospital)
Session information
Oral Session
Oral Session 1-14B ALL: Basic (2)
Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.14 (Osaka International Convention Center, 8F 801-2)
Chair: Fumihiko Hyakawa (Department of Pathophysiological Laboratory Sciences, Nagoya University Guraduate School of Medicine, Japan)
Yosuke Tanaka1, Masahito Kawazu1, Takahiko Yasuda2, Fumihiko Hayakawa3, Hitoshi Kiyoi3, Tomoki Naoe2, Hiroyuki Mano1 (1.Departments of Cellular Signaling, NCC, Tokyo, Japan, 2.National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 3.Department of Hematology and Oncology, Nagoya University, Nagoya, Japan)
Hideyuki Yamamoto1, Fumihiko Hayakawa1,2, Takahiko Yasuda3, Yuka Minamikawa4, Naoyuki Tange1, Daiki Hirano1, Yuki Kojima1, Takanobu Morishita1, Shinobu Tsuzuki5, Hiroyuki Mano6, Tomoki Naoe7, Hitoshi Kiyoi1 (1.Hematol. and Oncol., Nagoya Univ., Nagoya, Japan, 2.Department of Pathophysiological Laboratory Sciences, Nagoya Univ., Nagoya, Japan, 3.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 4.Department of Analytical Neurobiology, Meijo Univ., Nagoya, Japan, 5.Department of Biochemistry, Aichi Medical Univ., Nagakute, Japan, 6.National Cancer Center Research Institute, Tokyo, Japan, 7.Nagoya Medical Center, Nagoya, Japan)
Takahiko Yasuda1, Dai Nishijima1, Shinya Kojima2, Masahito Kawazu2, Toshihide Ueno2, Shinobu Tsuzuki3, Hitoshi Kiyoi4, Itaru Matsumura5, Yasushi Miyazaki6, Keizo Horibe1, Hiroyuki Mano2, Tomoki Naoe7, Masashi Sanada1, Fumihiko Hayakawa4 (1.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 2.National Cancer Center Research Institute, Tokyo, Japan, 3.Department of Biochemistry, Aichi Medical University, School of Medicine, Japan, 4.Nagoya University Graduate school of Medicine, Nagoya, Japan, 5.Kinki University Faculty of Medicine, Osaka, Japan, 6.Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan, 7.Nagoya Medical Center, National Hospital Organization, Nagoya, Japan)
Hiroaki Shimizu1, Hiromasa Iino2, Takuma Ishizaki1, Kahoko Hatsumi2, Satoru Takada2, Akihiko Yokohama1, Takayuki Saitoh1, Toru Sakura2, Hiroshi Handa1 (1.Department of Hematology, Gunma University, 2.Leukemia Research Center, Saiseikai Maebashi Hospital)
Dai Nishijima1, Mitsuko Akaihata1, Yuka Iijima1, Tomomi Yamada2, Toshinori Hori2, Yuichi Shiraishi3, Hiroko Tanaka3, Satoru Miyano3, Keizo Horibe1, Masashi Sanada1 (1.Clinical Research Center, Nagoya Medi,cal Center, Nagoya, Japan, 2.Department of Pediatrics, Aichi Medical School of Medicine, 3.The Institute of Medical Science, University of Tokyo, Tokyo, Japan)